Semaglutide, the GLP-1 receptor agonist, is an FDA-approved injectable treatment for chronic weight loss programs. Semaglutide may also go by other names, including Ozempic, Rybelsus, and Wegovy. The drug functions by boosting the body’s natural insulin secretion, resulting in appetite suppression and weight loss. Scientific research has shown Semaglutide’s impressive effectiveness across multiple studies.Schedule a Conversation
Semaglutide is an injectable drug that mimics the function of the glucagon-like peptide-1 (GLP-1) hormone, which regulates appetite within the brain. The process suppresses appetite and results in other benefits, such as reduced blood sugar by limiting sugar production in the liver, which can prove helpful for pre-diabetics and individuals with type-2 diabetes.
Semaglutide treatment provides multiple benefits that can significantly enhance active weight loss programs. These positive long-term effects include:
The common side effects of Semaglutide include nausea, vomiting, constipation, and diarrhea. However, healthcare practitioners may effectively control these symptoms early in the treatment. Gradually, Semaglutide's potential side effects may diminish as your body grows accustomed to it.
Individuals suffering from pre-existing health conditions such as pancreatitis, decreased kidney function, low blood sugar, multiple endocrine neoplasia type 2, gallbladder disease, and diabetic retinopathy should avoid Semaglutide treatment. Speak with your specialized weight-loss consultant for a comprehensive list of conditions that require caution.
Aside from drug contraindications and the existing health conditions listed above, Semaglutide works well for patients with varying BMI, age, and ethnicity.
You will need to schedule an initial appointment with a qualified weight loss professional to
assess your health history and FDA recommendations for obesity treatment to determine your
suitability for the program. Upon approval, your weight loss professional will arrange to
start Semaglutide treatment with a low dosage, gradually rising to around 2.4mg per
Your weight loss expert administers the drug by injection once weekly under the skin of the thigh, upper arm, or abdomen, with or without meals.
Weight loss experts may prescribe Semaglutide treatment and other ongoing initiatives, such as personalized exercise plans, behavioral intervention, and lipotropic injections to improve metabolism. Research studies have shown that participants prescribed 2.4mg of Semaglutide once a week who adhere to a healthy lifestyle demonstrate a sustained and significant reduction in body weight.
Semaglutide is usually started at 0.25 mg weekly and is increased by 0.25 mg every four weeks until reaching the target or tolerated dose. In addition to weight loss results, studies show improved quality of life for 40% to 50% of participants.
Scientific findings have also shown that some Semaglutide users had regained their lost weight upon discontinuing treatment.